Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BQ.1.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.76ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CK.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.4.6.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.75.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.40ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DM.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.60ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.49ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CK.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.13ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.9.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDK.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.16.16ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KT.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LE.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.7.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.49.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.47ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.18ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XAY.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.55ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BY.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EA.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XJENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BR.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBF.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.29ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBF.8.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XAUENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XAY.1.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.25.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XADENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XABENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CH.1.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FT.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XALENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBWENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.3.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XAY.1.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.19ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GY.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBF.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used